Ben Phillips, Chief Investment Officer at EventShares, a financial firm that creates ETFs based on political and other events, discusses the company's latest fund focused on the tax reform bill.
For each ETF, EventShares chooses stocks that stand to benefit based on the policies put forth by each party. The tax reform ETF functions the same way. Phillips adds that EventShares has the ability to re-balance the ETF as needed, based on the conversation coming out of Washington.
We talk about how the reform bill will impact indexes as a whole, but Phillips adds that he does not think that investing in specific indices is the way to go. He believes that investors can profit the most off of tax reform through an ETF with carefully curated companies.
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
